Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Suspended × Has results × Clear all

Phase

Phase 3 1 Phase 2 1

Status

Completed 4622 Terminated 1793 Active not recruiting 320 Unknown 25 Suspended 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1 Lymphoid 1

Conditions

Lymphoma 1 Histiocytic Sarcoma 1 Dendritic Cell Sarcoma, Interdigitating 1 Dendritic Cell Sarcoma, Follicular 1

Interventions

pembrolizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03316573 2026-02-10

Pembrolizumab in Neoplasms or Lymphomas

Dana-Farber Cancer Institute

Phase 2 Suspended

18 enrolled 16 charts

LymphoidSarcoma

Lymphoma, Dendritic Cell Sarcoma, Interdigitating, Dendritic Cell Sarcoma, Follicular, Histiocytic Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡